APO Research
Talk to an analyst

APO RESEARCH · REPORT

BDZs Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global BDZs Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchBDZs Drugs Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal BDZs Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal BDZs Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BDZs Drugs Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal BDZs Drugs Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global BDZs Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for BDZs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for BDZs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for BDZs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for BDZs Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of BDZs Drugs include Akorn, ANI Pharmaceuticals, Apotex, Bausch Health, CHEPLAPHARM, Fresenius Kabi, Hikma, Neurelis and Par Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global BDZs Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of BDZs Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BDZs Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the BDZs Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

BDZs Drugs Segment by Company

Akorn

ANI Pharmaceuticals

Apotex

Bausch Health

CHEPLAPHARM

Fresenius Kabi

Hikma

Neurelis

Par Pharmaceuticals

Sun Pharma

Torrent Pharma

WG Critical Care

Changzhou Siyao Pharmaceutical

Huazhong Pharmaceutical

Pfizer

Kaifeng Pharmaceutical

Roche

Mylan

Sandoz

Shanghai Pharmaceuticals Holding

Teva

Takeda

BDZs Drugs Segment by Type

Oral

Injection

BDZs Drugs Segment by Application

Insomnia

Alcohol Withdrawal Syndrome

Anxiety Disorders

Muscle Spasms

Epilepsy

Other

BDZs Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BDZs Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BDZs Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BDZs Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the BDZs Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of BDZs Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of BDZs Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of BDZs Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. BDZs Drugs Industry Trends Table 2. BDZs Drugs Industry Drivers Table 3. BDZs Drugs Industry Opportunities and Challenges Table 4. BDZs Drugs Industry Restraints Table 5. Global BDZs Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global BDZs Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global BDZs Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global BDZs Drugs Sales Market Share by Manufacturers Table 9. Global BDZs Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global BDZs Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global BDZs Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global BDZs Drugs Manufacturers, Product Type & Application Table 13. Global BDZs Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global BDZs Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global BDZs Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global BDZs Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global BDZs Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global BDZs Drugs Sales Market Share by Type (2021-2026) Table 22. Global BDZs Drugs Sales Market Share by Type (2027-2032) Table 23. Global BDZs Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global BDZs Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global BDZs Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global BDZs Drugs Revenue Market Share by Type (2021-2026) Table 27. Global BDZs Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Insomnia Table 29. Major Manufacturers of Alcohol Withdrawal Syndrome Table 30. Major Manufacturers of Anxiety Disorders Table 31. Major Manufacturers of Muscle Spasms Table 32. Major Manufacturers of Epilepsy Table 33. Major Manufacturers of Other Table 34. Global BDZs Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global BDZs Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global BDZs Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global BDZs Drugs Sales Market Share by Application (2021-2026) Table 38. Global BDZs Drugs Sales Market Share by Application (2027-2032) Table 39. Global BDZs Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global BDZs Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global BDZs Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global BDZs Drugs Revenue Market Share by Application (2021-2026) Table 43. Global BDZs Drugs Revenue Market Share by Application (2027-2032) Table 44. Global BDZs Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global BDZs Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global BDZs Drugs Sales Market Share by Region (2021-2026) Table 47. Global BDZs Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global BDZs Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America BDZs Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America BDZs Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe BDZs Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe BDZs Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific BDZs Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific BDZs Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa BDZs Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa BDZs Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global BDZs Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global BDZs Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global BDZs Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global BDZs Drugs Revenue Market Share by Region (2021-2026) Table 65. Global BDZs Drugs Revenue Market Share by Region (2027-2032) Table 66. Akorn Company Information Table 67. Akorn Business Overview Table 68. Akorn BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Akorn BDZs Drugs Product Portfolio Table 70. Akorn Recent Development Table 71. ANI Pharmaceuticals Company Information Table 72. ANI Pharmaceuticals Business Overview Table 73. ANI Pharmaceuticals BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ANI Pharmaceuticals BDZs Drugs Product Portfolio Table 75. ANI Pharmaceuticals Recent Development Table 76. Apotex Company Information Table 77. Apotex Business Overview Table 78. Apotex BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Apotex BDZs Drugs Product Portfolio Table 80. Apotex Recent Development Table 81. Bausch Health Company Information Table 82. Bausch Health Business Overview Table 83. Bausch Health BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Bausch Health BDZs Drugs Product Portfolio Table 85. Bausch Health Recent Development Table 86. CHEPLAPHARM Company Information Table 87. CHEPLAPHARM Business Overview Table 88. CHEPLAPHARM BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CHEPLAPHARM BDZs Drugs Product Portfolio Table 90. CHEPLAPHARM Recent Development Table 91. Fresenius Kabi Company Information Table 92. Fresenius Kabi Business Overview Table 93. Fresenius Kabi BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Fresenius Kabi BDZs Drugs Product Portfolio Table 95. Fresenius Kabi Recent Development Table 96. Hikma Company Information Table 97. Hikma Business Overview Table 98. Hikma BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Hikma BDZs Drugs Product Portfolio Table 100. Hikma Recent Development Table 101. Neurelis Company Information Table 102. Neurelis Business Overview Table 103. Neurelis BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Neurelis BDZs Drugs Product Portfolio Table 105. Neurelis Recent Development Table 106. Par Pharmaceuticals Company Information Table 107. Par Pharmaceuticals Business Overview Table 108. Par Pharmaceuticals BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Par Pharmaceuticals BDZs Drugs Product Portfolio Table 110. Par Pharmaceuticals Recent Development Table 111. Sun Pharma Company Information Table 112. Sun Pharma Business Overview Table 113. Sun Pharma BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Sun Pharma BDZs Drugs Product Portfolio Table 115. Sun Pharma Recent Development Table 116. Torrent Pharma Company Information Table 117. Torrent Pharma Business Overview Table 118. Torrent Pharma BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Torrent Pharma BDZs Drugs Product Portfolio Table 120. Torrent Pharma Recent Development Table 121. WG Critical Care Company Information Table 122. WG Critical Care Business Overview Table 123. WG Critical Care BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. WG Critical Care BDZs Drugs Product Portfolio Table 125. WG Critical Care Recent Development Table 126. Changzhou Siyao Pharmaceutical Company Information Table 127. Changzhou Siyao Pharmaceutical Business Overview Table 128. Changzhou Siyao Pharmaceutical BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Changzhou Siyao Pharmaceutical BDZs Drugs Product Portfolio Table 130. Changzhou Siyao Pharmaceutical Recent Development Table 131. Huazhong Pharmaceutical Company Information Table 132. Huazhong Pharmaceutical Business Overview Table 133. Huazhong Pharmaceutical BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Huazhong Pharmaceutical BDZs Drugs Product Portfolio Table 135. Huazhong Pharmaceutical Recent Development Table 136. Pfizer Company Information Table 137. Pfizer Business Overview Table 138. Pfizer BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Pfizer BDZs Drugs Product Portfolio Table 140. Pfizer Recent Development Table 141. Kaifeng Pharmaceutical Company Information Table 142. Kaifeng Pharmaceutical Business Overview Table 143. Kaifeng Pharmaceutical BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Kaifeng Pharmaceutical BDZs Drugs Product Portfolio Table 145. Kaifeng Pharmaceutical Recent Development Table 146. Roche Company Information Table 147. Roche Business Overview Table 148. Roche BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Roche BDZs Drugs Product Portfolio Table 150. Roche Recent Development Table 151. Mylan Company Information Table 152. Mylan Business Overview Table 153. Mylan BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Mylan BDZs Drugs Product Portfolio Table 155. Mylan Recent Development Table 156. Sandoz Company Information Table 157. Sandoz Business Overview Table 158. Sandoz BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Sandoz BDZs Drugs Product Portfolio Table 160. Sandoz Recent Development Table 161. Shanghai Pharmaceuticals Holding Company Information Table 162. Shanghai Pharmaceuticals Holding Business Overview Table 163. Shanghai Pharmaceuticals Holding BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Shanghai Pharmaceuticals Holding BDZs Drugs Product Portfolio Table 165. Shanghai Pharmaceuticals Holding Recent Development Table 166. Teva Company Information Table 167. Teva Business Overview Table 168. Teva BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Teva BDZs Drugs Product Portfolio Table 170. Teva Recent Development Table 171. Takeda Company Information Table 172. Takeda Business Overview Table 173. Takeda BDZs Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Takeda BDZs Drugs Product Portfolio Table 175. Takeda Recent Development Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. BDZs Drugs Distributors List Table 179. BDZs Drugs Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. BDZs Drugs Product Image Figure 2. Global BDZs Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BDZs Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global BDZs Drugs Sales (2021-2032) & (K Units) Figure 5. Global BDZs Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 BDZs Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global BDZs Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global BDZs Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global BDZs Drugs Sales Market Share by Type (2021-2032) Figure 13. Global BDZs Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global BDZs Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global BDZs Drugs Revenue Market Share by Type (2021-2032) Figure 16. Insomnia Image Figure 17. Alcohol Withdrawal Syndrome Image Figure 18. Anxiety Disorders Image Figure 19. Muscle Spasms Image Figure 20. Epilepsy Image Figure 21. Other Image Figure 22. Global BDZs Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global BDZs Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global BDZs Drugs Sales Market Share by Application (2021-2032) Figure 25. Global BDZs Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global BDZs Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global BDZs Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America BDZs Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe BDZs Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific BDZs Drugs Sales Market Share by Country (2021-2032) Figure 42. China BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa BDZs Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile BDZs Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global BDZs Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global BDZs Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America BDZs Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe BDZs Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific BDZs Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa BDZs Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. BDZs Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. BDZs Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Insomnia
  • Alcohol Withdrawal Syndrome
  • Anxiety Disorders
  • Muscle Spasms
  • Epilepsy
  • Other
Companies covered
  • Akorn
  • ANI Pharmaceuticals
  • Apotex
  • Bausch Health
  • CHEPLAPHARM
  • Fresenius Kabi
  • Hikma
  • Neurelis
  • Par Pharmaceuticals
  • Sun Pharma
  • Torrent Pharma
  • WG Critical Care
  • Changzhou Siyao Pharmaceutical
  • Huazhong Pharmaceutical
  • Pfizer
  • Kaifeng Pharmaceutical
  • Roche
  • Mylan
  • Sandoz
  • Shanghai Pharmaceuticals Holding
  • Teva
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global BDZs Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global BDZs Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global BDZs Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global BDZs Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global BDZs Drugs Market Dynamics
  1. 2.1 BDZs Drugs Industry Trends
  2. 2.2 BDZs Drugs Industry Drivers
  3. 2.3 BDZs Drugs Industry Opportunities and Challenges
  4. 2.4 BDZs Drugs Industry Restraints
3 BDZs Drugs Market by Manufacturers
  1. 3.1 Global BDZs Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global BDZs Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global BDZs Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global BDZs Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global BDZs Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global BDZs Drugs Manufacturers, Product Type & Application
  7. 3.7 Global BDZs Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global BDZs Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 BDZs Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 BDZs Drugs Tier 1, Tier 2, and Tier 3
4 BDZs Drugs Market by Type
  1. 4.1 BDZs Drugs Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global BDZs Drugs Sales by Type
  5. 4.2.1 Global BDZs Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global BDZs Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global BDZs Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global BDZs Drugs Revenue by Type
  9. 4.3.1 Global BDZs Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global BDZs Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global BDZs Drugs Revenue Market Share by Type (2021-2032)
5 BDZs Drugs Market by Application
  1. 5.1 BDZs Drugs Application Introduction
  2. 5.1.1 Insomnia
  3. 5.1.2 Alcohol Withdrawal Syndrome
  4. 5.1.3 Anxiety Disorders
  5. 5.1.4 Muscle Spasms
  6. 5.1.5 Epilepsy
  7. 5.1.6 Other
  8. 5.2 Global BDZs Drugs Sales by Application
  9. 5.2.1 Global BDZs Drugs Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global BDZs Drugs Sales by Application (2021-2032)
  11. 5.2.3 Global BDZs Drugs Sales Market Share by Application (2021-2032)
  12. 5.3 Global BDZs Drugs Revenue by Application
  13. 5.3.1 Global BDZs Drugs Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global BDZs Drugs Revenue by Application (2021-2032)
  15. 5.3.3 Global BDZs Drugs Revenue Market Share by Application (2021-2032)
6 Global BDZs Drugs Sales by Region
  1. 6.1 Global BDZs Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BDZs Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global BDZs Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global BDZs Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America BDZs Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe BDZs Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific BDZs Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa BDZs Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa BDZs Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global BDZs Drugs Revenue by Region
  1. 7.1 Global BDZs Drugs Revenue by Region
  2. 7.1.1 Global BDZs Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global BDZs Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global BDZs Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global BDZs Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America BDZs Drugs Revenue (2021-2032)
  8. 7.2.2 North America BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe BDZs Drugs Revenue (2021-2032)
  11. 7.3.2 Europe BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific BDZs Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa BDZs Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa BDZs Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn BDZs Drugs Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 ANI Pharmaceuticals
  8. 8.2.1 ANI Pharmaceuticals Company Information
  9. 8.2.2 ANI Pharmaceuticals Business Overview
  10. 8.2.3 ANI Pharmaceuticals BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ANI Pharmaceuticals BDZs Drugs Product Portfolio
  12. 8.2.5 ANI Pharmaceuticals Recent Developments
  13. 8.3 Apotex
  14. 8.3.1 Apotex Company Information
  15. 8.3.2 Apotex Business Overview
  16. 8.3.3 Apotex BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Apotex BDZs Drugs Product Portfolio
  18. 8.3.5 Apotex Recent Developments
  19. 8.4 Bausch Health
  20. 8.4.1 Bausch Health Company Information
  21. 8.4.2 Bausch Health Business Overview
  22. 8.4.3 Bausch Health BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bausch Health BDZs Drugs Product Portfolio
  24. 8.4.5 Bausch Health Recent Developments
  25. 8.5 CHEPLAPHARM
  26. 8.5.1 CHEPLAPHARM Company Information
  27. 8.5.2 CHEPLAPHARM Business Overview
  28. 8.5.3 CHEPLAPHARM BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CHEPLAPHARM BDZs Drugs Product Portfolio
  30. 8.5.5 CHEPLAPHARM Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi BDZs Drugs Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 Hikma
  38. 8.7.1 Hikma Company Information
  39. 8.7.2 Hikma Business Overview
  40. 8.7.3 Hikma BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hikma BDZs Drugs Product Portfolio
  42. 8.7.5 Hikma Recent Developments
  43. 8.8 Neurelis
  44. 8.8.1 Neurelis Company Information
  45. 8.8.2 Neurelis Business Overview
  46. 8.8.3 Neurelis BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Neurelis BDZs Drugs Product Portfolio
  48. 8.8.5 Neurelis Recent Developments
  49. 8.9 Par Pharmaceuticals
  50. 8.9.1 Par Pharmaceuticals Company Information
  51. 8.9.2 Par Pharmaceuticals Business Overview
  52. 8.9.3 Par Pharmaceuticals BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Par Pharmaceuticals BDZs Drugs Product Portfolio
  54. 8.9.5 Par Pharmaceuticals Recent Developments
  55. 8.10 Sun Pharma
  56. 8.10.1 Sun Pharma Company Information
  57. 8.10.2 Sun Pharma Business Overview
  58. 8.10.3 Sun Pharma BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharma BDZs Drugs Product Portfolio
  60. 8.10.5 Sun Pharma Recent Developments
  61. 8.11 Torrent Pharma
  62. 8.11.1 Torrent Pharma Company Information
  63. 8.11.2 Torrent Pharma Business Overview
  64. 8.11.3 Torrent Pharma BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Torrent Pharma BDZs Drugs Product Portfolio
  66. 8.11.5 Torrent Pharma Recent Developments
  67. 8.12 WG Critical Care
  68. 8.12.1 WG Critical Care Company Information
  69. 8.12.2 WG Critical Care Business Overview
  70. 8.12.3 WG Critical Care BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 WG Critical Care BDZs Drugs Product Portfolio
  72. 8.12.5 WG Critical Care Recent Developments
  73. 8.13 Changzhou Siyao Pharmaceutical
  74. 8.13.1 Changzhou Siyao Pharmaceutical Company Information
  75. 8.13.2 Changzhou Siyao Pharmaceutical Business Overview
  76. 8.13.3 Changzhou Siyao Pharmaceutical BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Changzhou Siyao Pharmaceutical BDZs Drugs Product Portfolio
  78. 8.13.5 Changzhou Siyao Pharmaceutical Recent Developments
  79. 8.14 Huazhong Pharmaceutical
  80. 8.14.1 Huazhong Pharmaceutical Company Information
  81. 8.14.2 Huazhong Pharmaceutical Business Overview
  82. 8.14.3 Huazhong Pharmaceutical BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Huazhong Pharmaceutical BDZs Drugs Product Portfolio
  84. 8.14.5 Huazhong Pharmaceutical Recent Developments
  85. 8.15 Pfizer
  86. 8.15.1 Pfizer Company Information
  87. 8.15.2 Pfizer Business Overview
  88. 8.15.3 Pfizer BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pfizer BDZs Drugs Product Portfolio
  90. 8.15.5 Pfizer Recent Developments
  91. 8.16 Kaifeng Pharmaceutical
  92. 8.16.1 Kaifeng Pharmaceutical Company Information
  93. 8.16.2 Kaifeng Pharmaceutical Business Overview
  94. 8.16.3 Kaifeng Pharmaceutical BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kaifeng Pharmaceutical BDZs Drugs Product Portfolio
  96. 8.16.5 Kaifeng Pharmaceutical Recent Developments
  97. 8.17 Roche
  98. 8.17.1 Roche Company Information
  99. 8.17.2 Roche Business Overview
  100. 8.17.3 Roche BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Roche BDZs Drugs Product Portfolio
  102. 8.17.5 Roche Recent Developments
  103. 8.18 Mylan
  104. 8.18.1 Mylan Company Information
  105. 8.18.2 Mylan Business Overview
  106. 8.18.3 Mylan BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Mylan BDZs Drugs Product Portfolio
  108. 8.18.5 Mylan Recent Developments
  109. 8.19 Sandoz
  110. 8.19.1 Sandoz Company Information
  111. 8.19.2 Sandoz Business Overview
  112. 8.19.3 Sandoz BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Sandoz BDZs Drugs Product Portfolio
  114. 8.19.5 Sandoz Recent Developments
  115. 8.20 Shanghai Pharmaceuticals Holding
  116. 8.20.1 Shanghai Pharmaceuticals Holding Company Information
  117. 8.20.2 Shanghai Pharmaceuticals Holding Business Overview
  118. 8.20.3 Shanghai Pharmaceuticals Holding BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shanghai Pharmaceuticals Holding BDZs Drugs Product Portfolio
  120. 8.20.5 Shanghai Pharmaceuticals Holding Recent Developments
  121. 8.21 Teva
  122. 8.21.1 Teva Company Information
  123. 8.21.2 Teva Business Overview
  124. 8.21.3 Teva BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Teva BDZs Drugs Product Portfolio
  126. 8.21.5 Teva Recent Developments
  127. 8.22 Takeda
  128. 8.22.1 Takeda Company Information
  129. 8.22.2 Takeda Business Overview
  130. 8.22.3 Takeda BDZs Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Takeda BDZs Drugs Product Portfolio
  132. 8.22.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 BDZs Drugs Value Chain Analysis
  2. 9.1.1 BDZs Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 BDZs Drugs Production Mode & Process
  6. 9.2 BDZs Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 BDZs Drugs Distributors
  9. 9.2.3 BDZs Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst